Printer Friendly

Articles from M2 Pharma (August 20, 2015)

1-17 out of 17 article(s)
Title Author Type Words
Alevicyn SG antipruritic spray gel launched by Oculus Innovative Sciences. 175
American Pharmacists Association Adds PharmaJet Needle-Free Injector to Educational Curriculum. 175
Amgen signs multi-year partnership with Center for Social Sector Leadership at the University of California, Berkeley's Haas School of Business. 128
BioMarin awarded US FDA's rare pediatric disease designation for Drisapersen for the potential treatment of DMD. 238
Boston Scientific passes US FDA approval for Innova Vascular Self-Expanding Stent System for treating PAD. 241
Catheter Market to Reach USD 46.05bn, Grand View Research Predicts. 416
Corbus Pharmaceuticals Holdings awarded US FDA's fast track designation for the investigation of Resunab for systemic sclerosis. 234
Eltel posts net result of EUR8.3m in April to June 2015 quarter. Financial report 139
Fourth Patient Enrolled in InVivo Therapeutics' Pilot Spinal Cord Injury Trial. 364
Guided Therapeutics Participates in Kenyan Cervical Cancer Screening Programme. 484
Hi-Tech Pharmaceuticals acquires LG Sciences brand of Sports Nutrition products and Bodybuilding products. 203
Hospira registers first monoclonal antibody biosimilar therapy in Australia for treating eight inflammatory conditions. 235
Medical Imaging Equipment Market will be Worth USD 35.35bn by 2019, According to Market Research Report. Report 527
Medical Polymers Market Worth USD 17.05bn by 2020, Estimates Grand View Research. 561
Merck Sharp and Dohme recalls 276,000 bottles with Temodar and Temozolomide capsules. 122
Orphan Biovitrum and A Menarini Australia receive marketing authorisation for Kineret in Australia. 174
ViewRay Raises USD 29.4m from Private Placement of Shares. 231

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters